Simplify Logo

Full-Time

Pioneering Medicines: Project Toxicologist – Principal Scientist or Associate Director

Toxicology

Posted on 10/17/2024

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Hybrid model requiring onsite presence 3 times per week.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • + BS/BA in toxicology, pharmacology, physiology, biology, immunology or related sciences with +10 years experience,
  • + MA/MS in in toxicology, pharmacology, physiology, biology, immunology or related sciences with +8 years experience, or
  • + D. in toxicology, pharmacology, physiology, biology, immunology or related discipline with +5 years experience in preclinical/nonclinical safety, pharmacology, and/or biology experience in the pharmaceutical/biotechnology industry
  • Strong lab, organization, and prioritizing skills to move programs forward
  • Strong critical thinking and analytical skills
  • Ability to learn quickly and creatively apply technologies (tried and true as well as new)
  • Ability to adapt to a rapidly changing and growing environment
  • Ability to multi-task and work with minimal guidance
  • Excellent oral/written communication and interpersonal skills
  • Ability to work well with team members from a broad range of levels and experience
Responsibilities
  • Serve as the project toxicologist for projects at various stages of discovery and development
  • Conduct safety assessments (on- and off-target)
  • Contribute to study design, planning, execution, and monitoring of external non-GLP and GLP toxicology studies (*in vitro* and *in vivo*) studies
  • Contribute to the development of an *in silico* and *in vitro* screening strategy to understand potential toxicological liabilities for new modalities
  • Manage contracts and coordinate activities with CROs for non-GLP and GLP toxicology studies
  • Support the preparation of study reports with external labs
  • Lead the preparation of regulatory documents, including INDs, investigator’s brochures, and NDAs/BLAs
  • Work closely with other functional areas such as biology, *in vitro* and *in vivo* pharmacology, DMPK, modeling and simulations, CMC and Clinical as well as internal and external collaborators

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?